The trial is for idiopathic pulmonary fibrosis.

'The company said the drug, INS018_055, was the first entirely “AI-discovered and AI designed” drug to begin a phase 2 clinical trial and represented an important milestone for the industry.'
#drugdiscovery #drugdevelopment #artificialintelligence

https://www.ft.com/content/82071cf2-f0da-432b-b815-606d602871fc